Doctors Are Using A New Method Of Treatment Of Peyronie's Disease.
The at the outset upper treatment for unusual curvature of the penis has been approved by the US Food and Drug Administration, the instrumentality announced Friday Dec 2013. Men with the condition, called Peyronie's disease, have a wad in the penis that causes curvature of at least 30 degrees during an erection. The disorder, which is caused by scratch tissue under the skin of the penis, can cause bothersome symptoms during sex.
Until now, surgery was the only medical way out for men with the condition, according to an FDA scandal release. The FDA's approval of the drug Xiaflex (collagenase clostridium histolyticum) to daily men with Peyronie's disease calls for a maximum of four treatment cycles. Each recycle consists of two injections and one penile remodeling procedure performed by a health care professional. The endorsement is based on two studies involving more than 800 men with Peyronie's disease.
Men who received the narcotize had significant reductions in penile curvature and related bothersome effects, compared to those who were given an lethargic placebo. The most common side effects associated with the use of Xiaflex are swelling and pain in the penis. There is a endanger for serious problems, including penile fracture, and the drug should be given by a health keeping professional with experience in treating male urological diseases, the FDA said.
Xiaflex was first approved by the FDA in 2010 to take out Dupuytren's contracture, a progressive hand disease that can affect a person's talent to straighten and use their fingers. The drug is believed to work for Peyronie's disease by breaking down the buildup of collagen (a structural protein in connective tissue) that causes the deformity in the penis, the FDA explained helpful resources. The stupefy is marketed by Pennsylvania-based Auxilium Pharmaceuticals, Inc More dirt The US National Kidney and Urologic Diseases Information Clearinghouse has more about Peyronie's disease.
No comments:
Post a Comment